Farrell D H, Van Nostrand W E, Cunningham D D
Biochem J. 1986 Aug 1;237(3):907-12. doi: 10.1042/bj2370907.
This paper describes a simple purification procedure for protease nexin, a serine proteinase inhibitor secreted by cultured human fibroblasts that regulates proteinase activity at and near the cell surface. The first step in the procedure takes advantage of the high-affinity binding of protease nexin to dextran sulphate-Sepharose. This step eliminates the need for prior concentration of the serum-free fibroblast-conditioned medium, since protease nexin binds to the resin in the presence of physiological saline. The use of dextran sulphate also provides an affinity resin with considerably less variability than the heparin-based resins previously used. Final purification to homogeneity involves a combination of DEAE-Sepharose in-line with dextran sulphate-Sepharose to simultaneously purify and concentrate the protein. Purified protease nexin is shown by Ouchterlony analysis and peptide mapping to be immunologically and structurally distinct from antithrombin III and heparin cofactor II, two plasma proteinase inhibitors with similar properties.
本文描述了一种简单的蛋白酶连接蛋白纯化方法。蛋白酶连接蛋白是一种由培养的人成纤维细胞分泌的丝氨酸蛋白酶抑制剂,可调节细胞表面及附近的蛋白酶活性。该方法的第一步利用了蛋白酶连接蛋白与硫酸葡聚糖-琼脂糖的高亲和力结合。这一步无需事先浓缩无血清成纤维细胞条件培养基,因为蛋白酶连接蛋白在生理盐水存在下会与树脂结合。使用硫酸葡聚糖还提供了一种比先前使用的基于肝素的树脂变异性小得多的亲和树脂。最终纯化至同质状态涉及将DEAE-琼脂糖与硫酸葡聚糖-琼脂糖串联,以同时纯化和浓缩该蛋白。通过免疫双扩散分析和肽图谱分析表明,纯化的蛋白酶连接蛋白在免疫和结构上与抗凝血酶III和肝素辅因子II不同,后两者是两种具有相似性质的血浆蛋白酶抑制剂。